KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merck (MRK) Other Operating Expenses (2016 - 2026)

Merck has reported Other Operating Expenses over the past 17 years, most recently at $4.3 billion for Q1 2026.

  • Quarterly Other Operating Expenses rose 28.04% to $4.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $21.2 billion through Mar 2026, up 41.05% year-over-year, with the annual reading at $16.5 billion for FY2025, 8.99% up from the prior year.
  • Other Operating Expenses was $4.3 billion for Q1 2026 at Merck, down from $9.7 billion in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $9.7 billion in Q4 2025 and troughed at $3.4 billion in Q1 2025.
  • The 5-year median for Other Operating Expenses is $4.0 billion (2023), against an average of $4.7 billion.
  • Year-over-year, Other Operating Expenses tumbled 51.28% in 2024 and then soared 145.74% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $3.8 billion in 2022, then soared by 113.27% to $8.1 billion in 2023, then crashed by 51.28% to $4.0 billion in 2024, then soared by 145.74% to $9.7 billion in 2025, then tumbled by 55.42% to $4.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Other Operating Expenses are $4.3 billion (Q1 2026), $9.7 billion (Q4 2025), and $3.6 billion (Q3 2025).